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In Spain, diarrhea remains a major cause of illness
among infants and young children. To determine the preva-
lence of rotavirus genotypes and temporal and geographic
differences in strain distribution, a structured surveillance
study of hospitalized children <5 years of age with diarrhea
was initiated in different regions of Spain during 2005.
Rotavirus was detected alone in samples from 362 (55.2%)
samples and as a coinfection with other viruses in 41 sam-
ples (6.3%). Enteropathogenic bacterial agents were
detected in 4.9% of samples; astrovirus and norovirus RNA
was  detected in 3.2% and 12.0% samples, respectively;
and adenovirus antigen was detected in 1.8% samples.
Including mixed infections, the most predominant G type
was G9 (50.6%), followed by G3 (33.0%) and G1 (20.2%).
Infection with multiple rotavirus strains was detected in
>11.4% of the samples studied during 2005.
G
roup A rotaviruses are a major cause of severe diar-
rhea in infants. In developing countries, severe diar-
rhea caused by human rotavirus results in an estimated
500,000 to 608,000 childhood deaths annually; worldwide,
it results in ≈2 million hospitalizations (1,2).
Rotaviruses belong to the Reoviridae family. Viral par-
ticles are nonenveloped, and triple-layered protein capsids
enclose the genome of 11 dsRNA segments. The major
protein in the central layer of the viral capsid is VP6,
which determines 7 different groups of rotaviruses (A–G).
The outer layer of the viral capsid is composed of 2 struc-
tural proteins, VP4 (encoded by gene 4) and VP7 (encod-
ed by gene 7, 8, or 9, depending on the strain) (3). These 2
proteins carry the major antigenic determinants, which
elicit neutralizing antibodies and are thought to be type
specific. Group A rotaviruses are widespread in humans
and animals and are subdivided into distinct genotypes, G
and P(4). Epidemiologic studies of rotavirus infections are
increasingly showing that a great diversity of rotavirus
strains are cocirculating in the human population through-
out the world. The most common genotypes of group A
rotaviruses (≈90%), which cause dehydrating gastroenteri-
tis in infants and young children worldwide, were G1P[8],
G2P[4], G3P[8], and G4P[8]; G1P[8] is the most prevalent
worldwide (5). However, other G genotypes are epidemio-
logically important, such as G5 in Brazil, (6,7), G9 and
G10 in India (8,9), and G8 in Malawi (10).
In Spain, diarrhea remains an important cause of illness
among infants and young children. A study conducted
from 1998 through 2002 detected rotavirus in 1,155 (31%)
of 3,760 specimens tested. G1 was the predominant geno-
type detected (53%), followed by G4 (24%), G2 (14%),
G9 (6%), and G3 (2%) (11). The distribution of genotypes
indicated a genotypic shift over time: G4 strains predomi-
nated (57%) from 1998 through 2000, whereas G1 gradu-
ally increased to account for 75% from 2000 through 2002
(11). Similar studies conducted in other regions of Spain
indicated similar shifts in the prevalence of rotavirus geno-
types (12,13).
We conducted structured surveillance among children
with diarrhea who were hospitalized in 6 hospitals in
Spain; our primary goals were to determine the prevalence
of rotavirus diarrhea in hospitalized children, the G and P
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Materials and Methods
Hospitals and Patients
Stool samples were collected from children attending 6
public hospitals located in different healthcare areas
throughout Spain. These hospitals intentionally represent-
ed the geographic, climatic, and ethnic diversity of Spain.
Their respective catchment areas are shown in Table 1. The
study was conducted between January 2005 and January
2006 and included children <5years of age who were hos-
pitalized with acute gastroenteritis and from whom a stool
sample was obtained.
Acute gastroenteritis was defined as >3 looser-than-
normal stools within a 24-hour period or an episode of
forceful vomiting and any loose stool. To enable reporting
of test results to hospitals, stool specimens were labeled
with the date of collection and a unique surveillance iden-
tification number. Permission for enrollment in the study
was obtained from children’s legal guardians, and ethical
approval was obtained from the institutional review board
of the Hospital de La Ribera.
Specimen Collection and Testing 
Whole stool specimens were collected and transported
immediately to hospital laboratories and stored at 4ºC until
processing. All fecal samples were screened for
enteropathogenic bacterial agents by conventional culture
methods previously described (14).
Each month, specimens were sent to the reference lab-
oratory (Viral Gastroenteritis Unit, National Center for
Microbiology, Instituto de Salud Carlos III, Madrid,
Spain). A10% suspension in 0.1 mol/Lphosphate-buffered
saline (pH 7.2) was prepared and tested by reverse tran-
scription (RT)-PCR for rotavirus, astrovirus, norovirus,
and sapovirus (11,15,16) and by an immunochromato-
graphic method for enteric adenoviruses (14).
Nucleic Acid Extraction and G/P Rotavirus Typing
Viral RNAwas extracted from 250 µL of the 10% fecal
suspension by using the guanidine isothiocyanate method
and the Rnaid Spin Kit (BIO 101, Anachem Bioscience,
Bedfordshire, UK) according to the manufacturer’s
instructions, with slight modifications (16). RNAwas elut-
ed in 50 µL of RNase-free distilled water and stored at
–20ºC. To determine the G/P type patterns present in chil-
dren hospitalized from 2005 through 2006, a total of 98
rotavirus strains were P typed. G and P rotavirus genotyp-
ing were performed by using RT-PCR methods as previ-
ously reported (11,17).
DNA Sequencing and Analysis
Rotavirus amplicons were genetically characterized by
nucleotide sequencing of both strands of the amplified
PCR products. These products were purified by using
QIAquick PCR Purification kit (Qiagen, Valencia, CA,
USA) and then sequenced using an ABI PRISM BigDye
Terminator Cycle Sequencing Ready Reaction Kit
(Applied Biosystems, Foster City, CA, USA) on an ABI
automated sequencer (Applied Biosystems, model 3700).
Data analysis was performed by using Clustal for multiple
alignments and neighbor-joining and maximum parsimony
methods for phylogenetic analysis (Bionumerics, Kortrijk,
Belgium). Spanish strains were submitted to GenBank
under accession numbers DQ440613 through DQ440624.
Results
Microbiology
A total of 656 hospitalized children were enrolled.
Enteropathogenic bacterial strains were detected in 5.0%
of samples (Table 2). Astrovirus and norovirus RNA was
detected in 3.2% and 12.0% samples, respectively, and
adenovirus antigen in 1.8% samples.
Atotal of 403 rotavirus strains were detected. Rotavirus
was found alone in 362 (55.2%) samples but was found in
another 41 samples (6.3%) as a coinfection with other
viruses. The percentage of children with gastroenteritis
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Leon to 68.2% in Valencia (Table 2).
Rotavirus Characterization
G typing RT-PCR for rotavirus alone was performed on
362 samples positive for rotavirus but could not be deter-
mined in 10 (2.8%) samples. The G types detected, includ-
ing mixed infections with multiple rotavirus strains, are
shown in Table 3. Briefly, the most predominant G type
was G9 (50.6%), followed by G3 (33.0%), G1 (20.2%),
and G2 (7.1%); the least common G type was G4 (0.6%).
G1, previously reported as the most common G type in
Spain, was found in only 20.2% of rotavirus infections.
With the exceptions of Valencia and Albacete, where G1
and G3, respectively, were the predominant G types, the
results from all other regions showed a predominance of
G9. However, even in these 2 areas, G9 was the second
most common strain detected when cases with coinfection
were added (26.7% and 31.6%, respectively).
Common G/P combinations, infrequent patterns, and
mixed-infection combinations were all detected (Table 4).
G9P[8] (40%) and G3P[8] (31%) were the most common
combinations detected, but G types in combination with
P[6] and P[9] were also detected.
Using DNA sequencing and phylogenetic analysis of
partial sequences of the gene encoding VP7, we compared
2 G3 strains from this study with 9 G3 strains isolated pre-
viously in Spain. All G3 strains from Spain shared >99.0%
homology and were more closely related to each other than
to strains isolated in Italy, United Kingdom, India, and
China.
Discussion
Genetically and antigenically diverse rotavirus strains
cocirculate in humans. The prevalence of rotavirus geno-
types varies according to location and time. Throughout
the world, genotyping and serotyping studies have identi-
fied common cocirculating rotavirus types, and G1P[8],
G2P[4], G3P[8], and G4P[8] are the predominant strains.
However, from time to time, other less common geno-
types, such as G9P[8], G5P[8], and G8P[6], have been pre-
dominant in various countries (5).
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Table 2. Pathogens in children <5 years of age, hospitalized with gastroenteritis, by region, Spain, 2005–2006 
No. samples (%) 
Pathogen  Albacete  Cáceres  León  Fuenlabrada  Leganés  Valencia  Total samples (%) 
Rotavirus  79 (55.7)  87 (54.4)  29 (36.7)  29 (50.9)  123 (62.7)  15 (68.2)  362 (55.2) 
Astrovirus  0  4 (2.5)  0  1 (1.7)  0  0  5 (0.8) 
Adenovirus  3 (2.1)  0  1 (1.3)  0  7 (3.6)  0  11 (1.7) 
Norovirus  8 (5.6)  18 (11.3)  5 (6.3)  3 (5.3)  9 (4.6)  0  43 (6.5) 
EB*  16 (11.3)  0  4 (5.1)  3 (5.3)  9 (4.6)  0  32 (4.9) 
EB + adenovirus  1 (0.7)  0  0  0  0  0  1 (0.1) 
Rotavirus + astrovirus  1 (0.7)  1 (0.6)  2 (2.5)  0  5 (2.6)  1 (4.5)  10 (1.5) 
Rotavirus + norovirus  2 (1.4)  7 (4.4)  3 (3.8)  2 (3.5)  16 (8.2)  0  30 (4.6) 
Norovirus + astrovirus  0  0  0  2 (3.5)  3 (1.5)  0  5 (0.8) 
Norovirus + astrovirus + 
rotavirus 
0  0  0  0  1 (0.5)  0  1 (0.1) 
Negative specimens  32 (22.5)  43 (26.8)  35 (44.3)  17 (29.8)  23 (11.7)  6 (27.3)  156 (23.8) 
Total specimens†  142 (21.6)  160 (24.2)  79 (12.0)  57 (8.7)  196 (29.9)  22 (3.4)  656 
*EB, enteropathogenic bacteria. 
†Percentages of isolations per total specimens in each region were 77.5, 73.1, 55.7, 70.2, 88.3, 72.7, and 76.2, respectively. In Spain, previous studies have identified G1P[8] and
G4P[8] as the predominant cocirculating strains from 1996
through 2004 (11,17,18) (Table 5). However, in our study,
conducted in 2005 and 2006, a major shift in the predomi-
nant strains was detected. G9P[8] and G3P[8] have
become the predominant genotypes cocirculating in sever-
al regions of Spain, and infection with multiple rotavirus
strains was detected in 11.4% of the cases studied.
Since its widespread introduction into the human popu-
lation in 1995, G9P[8] has become one of the predominant
viruses worldwide. In 2 separate studies conducted in
Thailand (19,20), this genotype has been reported as the
predominant virus circulating from 2000 through 2002 and
in Brazil from 1999 through 2002 (21). G3P[8] has recent-
ly been reported as the predominant strain circulating in
the Japanese population (22).
Less common G- and P-type combinations were also
detected in this study. This finding may suggest either an
earlier reassortment between animal and human strains,
resulting in the emergence of strains such as G2P[6] and
G3P[9], or zoonotic transmission to humans of an animal
strain, as possibly occurred with G9P[6]. The VP4-geno-
types P[6] and P[9] are reported to be associated with
infection in pigs and cats, respectively. Although animal
rotavirus strains replicate poorly in humans and person-to-
person transmission is rare, the relatively high frequency
of multiple infections detected in this study suggests that
the opportunity for dual infection of a cell, and therefore
reassortments, exists (23).
The main limitations of this study are having only 1
year of data, the minimal variations in the sampling
schemes in each institution (frequency of sampling, test
procedures, motivations of investigators), and the small
sample size collected. Although the sampling strategy
enabled monitoring for rotavirus in a large number of chil-
dren, future studies with hospital-based surveillance
should be initiated in different areas of Spain, and even
Europe, with larger samples.
Morbidity rates worldwide and morbidity and mortali-
ty rates caused by diarrhea in developing countries remain
high despite efforts to improve sanitary conditions, water
quality, and the healthcare infrastructure. These high rates
have driven efforts to develop a safe and effective
rotavirus vaccine, and the World Health Organization has
recognized that developing a vaccine is a priority for
reducing infant deaths in developing countries. The level
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Table 5. Predominant cocirculating rotavirus strains, Spain, 1996–2006* 
Year, % 
Rotavirus 
G-type(s) 
1996–
1997† 
(n = 322)  
1998–
1999‡ 
(n = 141) 
1999–
2000‡ 
(n = 86) 
2000–
2001‡ 
(n = 200) 
2001–
2002‡ 
(n = 149) 
2002–
2003§ 
(n = 102) 
2003–
2004§ 
(n = 141) 
2004-
2005§ 
(n = 105) 
2005–
2006 
(n = 352) 
Average 
(%) 
(n = 1,598) 
G1 alone  68  18  27  70  79  79  79.5  50  17.1  54 
G2 alone  0  1  9  23  17  16  1  11  5  9 
G3 alone  2  1  12  0  0  0  17  7  24  7 
G4 alone  29  68  39  3  1  0  0  26  0.6  19 
G9 alone  0  11  13  3  2  3  1  5.4  39.5  9 
G1+G2  0  0  0  0  1  0  1.5  0.2  1.1  0 
G1+G4  1  1  0  1  0  2  0  0.4  0  1 
G1+G9  0  0  0  0  0  0  0  0  1.1  0 
G1+G3  0  0  0  0  0  0  0  0  0.3  0 
G2+G9  0  0  0  0  0  0  0  0  0.8  0 
G3+G9  0  0  0  0  0  0  0  0  7.7  1 
Undet.¶  0  0  0  0  0  0  0  0  2.8  0 
Total 
samples 
322  141  86  200  149  102  141  105  362  1,608 
*χ
2 test showed annual variations in G1, G2, G3, G4, and G9 prevalence rotavirus types and in G3 + G9 mixed infections (χ
2 = 15.50 with 8 degrees of 
freedom, p>0.95). 
†Adapted from Reference 11. 
‡Adapted from Reference 17. 
§Adapted from Reference 18.  
¶Undet., undetermined. 
 and type of protection in rotavirus disease is poorly under-
stood, although neutralizing antibody responses are
thought to be type specific. Because these responses are
associated with VP7 and VP4 viral proteins, establishing
the G and P genotypes of strains circulating in the human
population is important. Currently, 2 candidate rotavirus
vaccines are undergoing clinical trials. A multivalent vac-
cine directed against G1, G2, G3, G4, and P[8] and a
monovalent vaccine to G1P[8] have been developed
(24,25). Homotypic protection has been demonstrated for
both vaccines, but the degree to which they cross-protect
against less common G- and P-type combinations not
included in the vaccine formulations has yet to be estab-
lished, and the importance of genotype-specific protection
against rotavirus disease is still under discussion (26,27).
Considering that G9 rotavirus type has emerged as one of
the most common rotavirus genotypes in humans around
the world, and it is becoming very prevalent in some coun-
tries, future rotavirus vaccine candidates will need to pro-
vide adequate protection against disease caused by G9
viruses. Therefore, surveillance of regional networks must
be maintained to document rotavirus strain distribution
and prevent the appearance of new strains or new variants
that could escape immune protection induced by an outdat-
ed vaccine.
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